Northern Trust Corp Amicus Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

A detailed history of Northern Trust Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 3,047,354 shares of FOLD stock, worth $32.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,047,354
Previous 3,156,082 3.45%
Holding current value
$32.6 Million
Previous $37.2 Million 18.69%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$9.04 - $11.75 $982,901 - $1.28 Million
-108,728 Reduced 3.45%
3,047,354 $30.2 Million
Q1 2024

May 14, 2024
BUY
$11.43 - $14.24 $3.56 Million - $4.43 Million
311,331 Added 10.94%
3,156,082 $37.2 Million
Q4 2023

Feb 13, 2024
BUY
$9.97 - $14.52 $127,825 - $186,160
12,821 Added 0.45%
2,844,751 $40.4 Million
Q3 2023

Nov 13, 2023
BUY
$11.78 - $13.86 $183,862 - $216,326
15,608 Added 0.55%
2,831,930 $34.4 Million
Q2 2023

Aug 11, 2023
BUY
$10.72 - $13.3 $1.07 Million - $1.32 Million
99,488 Added 3.66%
2,816,322 $35.4 Million
Q1 2023

May 15, 2023
BUY
$10.91 - $13.54 $210,137 - $260,793
19,261 Added 0.71%
2,716,834 $30.1 Million
Q4 2022

Feb 13, 2023
BUY
$9.89 - $12.7 $335,122 - $430,339
33,885 Added 1.27%
2,697,573 $32.9 Million
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $298,655 - $387,765
-30,413 Reduced 1.13%
2,663,688 $27.8 Million
Q2 2022

Aug 12, 2022
BUY
$6.23 - $11.12 $34,022 - $60,726
5,461 Added 0.2%
2,694,101 $28.9 Million
Q1 2022

May 13, 2022
SELL
$7.89 - $12.48 $839,472 - $1.33 Million
-106,397 Reduced 3.81%
2,688,640 $25.5 Million
Q4 2021

Feb 08, 2022
SELL
$9.82 - $12.44 $353,156 - $447,379
-35,963 Reduced 1.27%
2,795,037 $32.3 Million
Q3 2021

Nov 15, 2021
SELL
$8.74 - $11.84 $1.09 Million - $1.47 Million
-124,285 Reduced 4.21%
2,831,000 $27 Million
Q2 2021

Aug 13, 2021
SELL
$8.71 - $10.72 $47,304 - $58,220
-5,431 Reduced 0.18%
2,955,285 $28.5 Million
Q1 2021

May 12, 2021
SELL
$9.2 - $23.86 $2.44 Million - $6.33 Million
-265,189 Reduced 8.22%
2,960,716 $29.3 Million
Q4 2020

Feb 11, 2021
SELL
$13.47 - $24.89 $1.06 Million - $1.96 Million
-78,592 Reduced 2.38%
3,225,905 $74.5 Million
Q3 2020

Nov 16, 2020
SELL
$12.89 - $15.89 $2.65 Million - $3.26 Million
-205,250 Reduced 5.85%
3,304,497 $46.7 Million
Q2 2020

Aug 14, 2020
BUY
$8.86 - $15.69 $1.26 Million - $2.23 Million
142,231 Added 4.22%
3,509,747 $52.9 Million
Q1 2020

May 14, 2020
BUY
$6.63 - $11.16 $256,362 - $431,523
38,667 Added 1.16%
3,367,516 $31.1 Million
Q4 2019

Feb 14, 2020
BUY
$7.48 - $10.75 $526,891 - $757,230
70,440 Added 2.16%
3,328,849 $32.4 Million
Q3 2019

Nov 13, 2019
BUY
$8.02 - $13.25 $4.8 Million - $7.93 Million
598,798 Added 22.51%
3,258,409 $26.1 Million
Q2 2019

Aug 13, 2019
BUY
$10.96 - $14.4 $1.5 Million - $1.97 Million
136,521 Added 5.41%
2,659,611 $33.2 Million
Q1 2019

May 13, 2019
BUY
$10.04 - $13.92 $810,227 - $1.12 Million
80,700 Added 3.3%
2,523,090 $34.3 Million
Q4 2018

Feb 12, 2019
SELL
$8.38 - $13.44 $29,221 - $46,865
-3,487 Reduced 0.14%
2,442,390 $23.4 Million
Q3 2018

Nov 14, 2018
BUY
$11.6 - $16.54 $596,089 - $849,940
51,387 Added 2.15%
2,445,877 $29.6 Million
Q2 2018

Sep 18, 2018
SELL
$13.13 - $17.09 $152,518 - $198,517
-11,616 Reduced 0.48%
2,394,490 $37.4 Million
Q2 2018

Aug 14, 2018
BUY
$13.13 - $17.09 $2.82 Million - $3.68 Million
215,060 Added 9.82%
2,406,106 $37.6 Million
Q1 2018

May 09, 2018
BUY
$13.76 - $17.12 $3.02 Million - $3.76 Million
219,558 Added 11.14%
2,191,046 $33 Million
Q4 2017

Feb 14, 2018
SELL
$12.51 - $16.24 $67,191 - $87,225
-5,371 Reduced 0.27%
1,971,488 $28.4 Million
Q3 2017

Nov 13, 2017
BUY
$11.74 - $15.78 $23.2 Million - $31.2 Million
1,976,859
1,976,859 $29.8 Million

Others Institutions Holding FOLD

# of Institutions
278
Shares Held
324M
Call Options Held
260K
Put Options Held
261K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email